Comparative test on the occurrence rate of side effects accompanying duloxetine oral dosing timing
Not Applicable
- Conditions
- chronic pain
- Registration Number
- JPRN-UMIN000026441
- Lead Sponsor
- Saku Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients under 25 years of age 2 A patient with suicide ideas and suicide attempts in the past 3 Patients with a history of hypersensitivity to the ingredients of this drug 4 Patients during monoamine oxidase inhibitor administration or within 2 weeks after discontinuation of administration 5 Patients with high liver damage or advanced renal impairment 6 Patient with poor control of closed angle glaucoma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Presence or absence of side effects within 4 weeks after starting oral administration
- Secondary Outcome Measures
Name Time Method